Skip to main content
Premium Trial:

Request an Annual Quote

Partek, Gulf Scientific, Greiner Bio-One, Invitrogen, OGT, Ocean Ridge Biosciences

Partek Signs up Gulf Scientific as Middle East Distributor
Partek said this week that Gulf Scientific, a life science technology supplier based in the United Arab Emirates, will supply customers throughout the Persian Gulf region with its software solutions.
Under the agreement, Gulf Scientific will market, distribute, and support Partek’s Genomics Suite, Discovery Suite, QSAR Solution, and Screener Solution in Saudi Arabia, Egypt, Kuwait, Qatar, Yemen, Oman, Bahrain, Iraq, Jordan, Lebanon, and the United Arab Emirates, Partek said.
Partek’s software packages include statistical analysis and interactive data visualization tools.
Financial terms of the agreement were not released.

Greiner Bio-One Licenses Invitrogen's PCR Sample-Prep Tech for HPV Test
Greiner Bio-One has licensed Invitrogen’s deoxyuridine triphosphate technology for use in a PCR-based HPV test and in DNA array products, the companies said last week.
Greiner Bio-One said it will use dUTP in place of deoxythymidine triphosphate to prevent false positives during PCR by reducing sample contamination.
The company said the use of dUTP will improve the reliability of its PapilloCheck HPV test and its DNA-array CytoCheck products. Greiner Bio-One will begin offering product kits for PapilloCheck with dUTP this month, and plans to offer dUTP-based kits for CytoCheck this fall.
Financial terms of the agreement were not released.

OGT Grants License to Ocean Ridge Biosciences
Oxford Gene Technology and Ocean Ridge Biosciences have completed a licence agreement granting ORB access to an OGT patent that will enable ORB to offer DNA expression and microRNA profiling services worldwide from its headquarters in Jupiter, Fla.
ORB Senior Scientist David Willoughby said the license will allow the firm to provide its services to the “general research community,” both locally in Florida and throughout the US and Canada, and will enable ORB to ”continue with our mission of improving human health through the provision of accurate, affordable, and information-rich genomic services.”
The licence will remain valid for the patents’ lifetime, OGT said.
Financial details were not disclosed.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.